Michael Byrnes

Insider Reports History

Entity
Individual
Location
C/O Ocera Therapeutics, Inc., 525 University Avenue, Suite 610, Palo Alto, CA
Signature
/s/ Brian G. Atwood, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Byrnes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
eFFECTOR Therapeutics, Inc. Chief Financial Officer Common Stock 3.12K $5.25K $1.68 May 15, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Director Stock Option (Right to Buy) 128K Dec 2, 2024 Direct
eFFECTOR Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 40K Feb 19, 2024 Direct

Insider Reports Filed by Michael Byrnes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERO CERO THERAPEUTICS HOLDINGS, INC. Dec 2, 2024 1 $0 4 Dec 4, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. May 15, 2024 1 $2.33K 4 May 17, 2024 Chief Financial Officer
CERO CERO THERAPEUTICS HOLDINGS, INC. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Feb 19, 2024 1 $0 4 Feb 21, 2024 Chief Financial Officer
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 0 $0 3 Feb 16, 2024 Director
EFTR eFFECTOR Therapeutics, Inc. Nov 15, 2023 1 $2.25K 4 Nov 16, 2023 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. May 15, 2023 1 $2.23K 4 May 16, 2023 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Jan 17, 2023 1 $0 4 Jan 19, 2023 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Nov 15, 2022 1 $2.18K 4 Nov 16, 2022 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Jun 20, 2022 1 $0 4 Jun 22, 2022 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Jun 7, 2022 1 $33.3K 4 Jun 7, 2022 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. May 13, 2022 1 $6.48K 4 May 17, 2022 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Aug 25, 2021 2 $0 4 Aug 27, 2021 Chief Financial Officer
EFTR eFFECTOR Therapeutics, Inc. Aug 24, 2021 0 $0 3 Aug 27, 2021 Chief Financial Officer